Literature DB >> 28368377

Prognostic impact of the European LeukemiaNet standardized reporting system in older AML patients receiving stem cell transplantation after non-myeloablative conditioning.

M Bill1, M Jentzsch1, J Grimm1, K Schubert1, T Lange1, M Cross1, G Behre1, V Vucinic1, W Pönisch1, G-N Franke1, D Niederwieser1, S Schwind1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28368377     DOI： 10.1038/bmt.2017.42

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.

Authors:  Ute Hegenbart; Dietger Niederwieser; Brenda M Sandmaier; Michael B Maris; Judith A Shizuru; Hildegard Greinix; Catherine Cordonnier; Bernard Rio; Alois Gratwohl; Thoralf Lange; Haifa Al-Ali; Barry Storer; David Maloney; Peter McSweeney; Thomas Chauncey; Ed Agura; Benedetto Bruno; Richard T Maziarz; Finn Petersen; Rainer Storb
Journal:  J Clin Oncol       Date:  2005-12-12       Impact factor: 44.544

2.  Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.

Authors:  Boglarka Gyurkocza; Rainer Storb; Barry E Storer; Thomas R Chauncey; Thoralf Lange; Judith A Shizuru; Amelia A Langston; Michael A Pulsipher; Christopher N Bredeson; Richard T Maziarz; Benedetto Bruno; Finn B Petersen; Michael B Maris; Edward Agura; Andrew Yeager; Wolfgang Bethge; Firoozeh Sahebi; Frederick R Appelbaum; David G Maloney; Brenda M Sandmaier
Journal:  J Clin Oncol       Date:  2010-05-03       Impact factor: 44.544

3.  Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

Authors:  Christian Thiede; Christine Steudel; Brigitte Mohr; Markus Schaich; Ulrike Schäkel; Uwe Platzbecker; Martin Wermke; Martin Bornhäuser; Markus Ritter; Andreas Neubauer; Gerhard Ehninger; Thomas Illmer
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

4.  Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation.

Authors:  Richard F Schlenk; Sabine Kayser; Lars Bullinger; Guido Kobbe; Jochen Casper; Mark Ringhoffer; Gerhard Held; Peter Brossart; Michael Lübbert; Helmut R Salih; Thomas Kindler; Heinz A Horst; Gerald Wulf; David Nachbaur; Katharina Götze; Alexander Lamparter; Peter Paschka; Verena I Gaidzik; Veronica Teleanu; Daniela Späth; Axel Benner; Jürgen Krauter; Arnold Ganser; Hartmut Döhner; Konstanze Döhner
Journal:  Blood       Date:  2014-09-30       Impact factor: 22.113

5.  FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

Authors:  Susan P Whitman; Kati Maharry; Michael D Radmacher; Heiko Becker; Krzysztof Mrózek; Dean Margeson; Kelsi B Holland; Yue-Zhong Wu; Sebastian Schwind; Klaus H Metzeler; Jing Wen; Maria R Baer; Bayard L Powell; Thomas H Carter; Jonathan E Kolitz; Meir Wetzler; Joseph O Moore; Richard M Stone; Andrew J Carroll; Richard A Larson; Michael A Caligiuri; Guido Marcucci; Clara D Bloomfield
Journal:  Blood       Date:  2010-07-23       Impact factor: 22.113

6.  Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

Authors:  Christian Thiede; Sina Koch; Eva Creutzig; Christine Steudel; Thomas Illmer; Markus Schaich; Gerhard Ehninger
Journal:  Blood       Date:  2006-02-02       Impact factor: 22.113

7.  Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A.

Authors:  Richard F Schlenk; Konstanze Döhner; Silja Mack; Michael Stoppel; Franz Király; Katharina Götze; Frank Hartmann; Heinz A Horst; Elisabeth Koller; Andreas Petzer; Wolfgang Grimminger; Guido Kobbe; Axel Glasmacher; Hans Salwender; Heinz Kirchen; Detlef Haase; Stephan Kremers; Axel Matzdorff; Axel Benner; Hartmut Döhner
Journal:  J Clin Oncol       Date:  2010-08-30       Impact factor: 44.544

Review 8.  Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

Authors:  Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel A Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

9.  Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.

Authors:  Krzysztof Mrózek; Guido Marcucci; Deedra Nicolet; Kati S Maharry; Heiko Becker; Susan P Whitman; Klaus H Metzeler; Sebastian Schwind; Yue-Zhong Wu; Jessica Kohlschmidt; Mark J Pettenati; Nyla A Heerema; AnneMarie W Block; Shivanand R Patil; Maria R Baer; Jonathan E Kolitz; Joseph O Moore; Andrew J Carroll; Richard M Stone; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2012-09-17       Impact factor: 44.544

10.  Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-.

Authors:  Jan M Middeke; Dietrich Beelen; Michael Stadler; Gudrun Göhring; Brigitte Schlegelberger; Herrad Baurmann; Gesine Bug; Frauke Bellos; Brigitte Mohr; Stefanie Buchholz; Rainer Schwerdtfeger; Hans Martin; Ute Hegenbart; Gerhard Ehninger; Martin Bornhäuser; Johannes Schetelig
Journal:  Blood       Date:  2012-07-31       Impact factor: 22.113
View more
  3 in total

1.  Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation.

Authors:  Juliane Grimm; Madlen Jentzsch; Marius Bill; Karoline Goldmann; Julia Schulz; Dietger Niederwieser; Uwe Platzbecker; Sebastian Schwind
Journal:  Blood Adv       Date:  2020-08-25

2.  Prognostic Impact of Blood MN1 Copy Numbers Before Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia.

Authors:  Madlen Jentzsch; Marius Bill; Juliane Grimm; Julia Schulz; Stefanie Beinicke; Janine Häntschel; Karoline Goldmann; Wolfram Pönisch; Georg-Nikolaus Franke; Vladan Vucinic; Michael Cross; Gerhard Behre; Thoralf Lange; Dietger Niederwieser; Sebastian Schwind
Journal:  Hemasphere       Date:  2019-02-08

3.  High BAALC copy numbers in peripheral blood prior to allogeneic transplantation predict early relapse in acute myeloid leukemia patients.

Authors:  Madlen Jentzsch; Marius Bill; Juliane Grimm; Julia Schulz; Karoline Goldmann; Stefanie Beinicke; Janine Häntschel; Wolfram Pönisch; Georg-Nikolaus Franke; Vladan Vucinic; Gerhard Behre; Thoralf Lange; Dietger Niederwieser; Sebastian Schwind
Journal:  Oncotarget       Date:  2017-09-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.